Provider review, September 2026

TrufaMED Review

TrufaMED charges one flat figure per NAD+ session with no milligram tiers, and says on the same page that the therapy is not approved by the regulator for anti-aging.

What TrufaMED charges

NAD+: $1000 — printed as '$1,000 per session' for a single in-clinic infusion, under the seller's own heading 'One protocol, one price. No mg-tiered upsells and no surprise add-ons.' A mobile session delivered to the patient is priced higher on the same page

TrufaMED is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit TrufaMED

By Nora Castellan, Standards EditorUpdated September 2026

One protocol, one price

The pricing sits under the seller's own heading saying one protocol, one price, with no milligram-tiered upsells and no surprise add-ons. The page then delivers exactly that.

There is a single flat figure for an in-clinic infusion. A mobile session delivered to the patient is published separately at a higher figure, so both options are visible before booking.

That is among the cleanest price disclosures in this batch. A reader knows the total before contact, which almost nothing else on this roster allows.

Per session is a unit a monthly board cannot absorb

The figure describes one infusion, not a month of treatment. How many sessions a person has in a month is not stated anywhere, so no monthly cost follows from it.

This review records the figure as not monthly and leaves it there. Multiplying a session price by an assumed frequency would manufacture a rate the seller never published.

Against a seller billing monthly, this is a different kind of purchase rather than a cheaper or dearer one. The comparison has to be made on those terms.

It states the regulatory position itself

The page says in its own words that NAD+ infusion is not approved by the regulator as an anti-aging therapy. That is the seller narrowing its own claim on the page selling the service.

Very few sellers in this market volunteer that. Most either avoid the subject or bury it in terms a buyer will never open.

The page also describes what each session includes rather than only what it costs, which lets a reader see what the flat figure is buying.

One compound, and no company named

NAD+ is the only tracked compound here, so there is nothing to compare within the seller and no broader menu to price against.

No corporate entity is published on the pages read. A reader who wants to know which company is behind the brand will not find it there.

No state list is published and no dispensing pharmacy is named, and nothing describes lab work as included in the session figure.

Who it's for

Buyers who want the total for a single infusion before booking.
Readers who want a flat figure with no milligram tiers, stated as such.
Anyone choosing between an in-clinic session and one delivered to them.
People who want a seller to state the regulatory limits of its own service.

Who should look elsewhere

Anyone comparing sellers on a monthly rate, since this figure is per session.
Readers who want more than one compound from a single provider.
Buyers who need the operating company or the dispensing pharmacy named.
Shoppers who need their own state confirmed on the public site.

Strengths

States a flat per-session price with no milligram tiers, and says so explicitly
Prices its in-clinic and mobile sessions separately and openly
States in its own words that the therapy is not FDA-approved for anti-aging
Describes what each session includes rather than only what it costs

Trade-offs

Prices per session, a unit nothing on a monthly comparison can absorb
Sells one tracked compound only, so there is nothing to compare within the seller
Publishes no corporate entity on any page read
Publishes no state list and names no dispensing pharmacy

How we verified this

Read the pricing page in full and recorded the in-clinic and mobile session figures as two separate products.
Recorded the figure as a per-session price and declined to convert it into a monthly rate, because the page states no session frequency.
Quoted the seller's own heading about a single protocol and a single price from the page it appears on.
Recorded the statement that NAD+ infusion is not approved by the regulator for anti-aging as the seller's own words.
Checked the pages read for a corporate entity, a state list, a named dispensing pharmacy and any lab work described as included.

A provider to compare TrufaMED against

Trellis Vitality

Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.

Read the full Trellis Vitality review

Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.

Visit Trellis Vitality

Frequently asked questions

Is this a monthly price?

No. It is the price of one infusion. The page states no session frequency, so nothing on it supports converting the figure into a monthly cost.

Does the dose change the price?

The seller says no. Its heading states one protocol and one price, with no milligram-tiered upsells and no surprise add-ons.

What is the difference between the two published figures?

One is an in-clinic session and the other is a mobile session delivered to the patient. The mobile figure is the higher of the two.

Is NAD+ infusion an approved anti-aging treatment?

The seller says it is not approved by the regulator for that purpose, on the same page that sells it. That is its own statement, and an unusually direct one.